Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Retained earnings	AOCI	Deferred Compensation, Share-Based Payments
Beginning balance (in shares) at Dec. 31, 2024		33,990,827
Beginning balance at Dec. 31, 2024	$ 863,527	$ 531,674	$ 387,097	$ (55,244)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)		149,937
Restricted stock units vested	0
Stock-based compensation expense	1,288				$ 1,288
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)		(35,248)
Common stock repurchased	(838)	$ (838)
Net income	13,911		13,911
Other comprehensive loss, net of tax	11,898			11,898
Cash dividends declared on common stock	8,271		8,271
Ending balance (in shares) at Mar. 31, 2025		34,105,516
Ending balance at Mar. 31, 2025	$ 881,515	$ 532,124	392,737	(43,346)
Beginning balance (in shares) at Dec. 31, 2025	33,963,500	33,963,500
Beginning balance at Dec. 31, 2025	$ 921,504	$ 531,100	421,619	(31,215)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)		157,333
Restricted stock units vested	0
Stock-based compensation expense	1,296				$ 1,296
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)		(38,560)
Common stock repurchased	(960)	$ (960)
Stock Issued During Period, Shares, Acquisitions		7,167,600
Stock Issued During Period, Value, Acquisitions	184,996	$ 184,996
Net income	18,947		18,947
Other comprehensive loss, net of tax	(1,781)			(1,781)
Cash dividends declared on common stock	$ 8,311		8,311
Ending balance (in shares) at Mar. 31, 2026	41,249,873	41,249,873
Ending balance at Mar. 31, 2026	$ 1,115,691	$ 716,432	$ 432,255	$ (32,996)